Bioavailability 101: Why the Dose on the Label Isn't the Dose You Absorb

If you read supplement labels closely, you probably already compare milligrams the way shoppers compare prices: more looks like better value. It is an intuitive assumption, and for many ingredients it is quietly wrong. The dose on the label is the amount put into the capsule. It is not the amount that reaches your bloodstream, your tissues, or the receptors where an ingredient does its work. That second number, the one no label prints, is bioavailability, and for poorly soluble compounds it can be a small fraction of the first.

This gap is why two products with identical labeled doses can produce completely different results. One is built so the active ingredient survives digestion and crosses into circulation. The other simply meets the number on the front of the bottle. Understanding the difference is the single most useful thing an ingredient-literate reader can learn about how supplements actually behave in the body.'

Key Takeaways

• Bioavailability is the fraction of a dose that actually reaches your bloodstream in an active form, and it can be far lower than the labeled amount for poorly soluble ingredients.
• A high milligram count means little if most of the compound never gets absorbed, which is why label dose and delivered dose are not the same measurement.
• Two compounds central to natural pain support, palmitoylethanolamide (PEA) and ginger's gingerols, are both notoriously difficult to absorb in their raw form.
• Delivery chemistry, such as binding an active to phospholipids, is a characterized way to raise absorption rather than simply raising the dose.
• The meaningful question is not how much is in the capsule, but how much your body can use.

What Bioavailability Actually Means: The Number No Label Prints

Bioavailability is the proportion of an ingested dose that reaches systemic circulation in a form the body can use. When a compound is injected directly into a vein, its bioavailability is 100% by definition. Everything taken by mouth is measured against that ceiling, and most oral compounds fall well short of it.

The reasons are physical. To be absorbed from the gut, a molecule generally has to dissolve in water to reach the intestinal lining, then cross a fatty cell membrane to enter the bloodstream. Compounds that are poorly water soluble struggle at the first step; compounds that are poorly fat soluble struggle at the second. Many of the most interesting natural bioactives are difficult on one axis or the other, which means a large share of the labeled dose can pass through undissolved and unabsorbed. The milligrams were real. They just never arrived.

Why Under-Dosed and Poorly Absorbed Actives Do Nothing

An active ingredient has to reach its target at a high enough concentration to have an effect. Two separate failures can prevent that. The first is under-dosing, where a formula includes an ingredient at a fraction of the amount used in the studies that made it interesting, often to fit many ingredients onto one label. The second, quieter failure is poor absorption, where the dose looks adequate on paper but little of it survives the trip through the gut.

The two failures compound. A modestly dosed ingredient with poor bioavailability can deliver so little usable compound that the result is indistinguishable from taking nothing at all. This is the mechanism behind a familiar disappointment: a scientifically promising ingredient, packaged in a way that guaranteed it could not perform, and then judged a failure when the delivery, not the ingredient, was at fault.

PEA and Ginger: Two Actives That Absorption Punishes

Two compounds at the center of natural pain support illustrate the problem precisely, because both are poorly bioavailable in their raw form.

PEA (palmitoylethanolamide) is a fatty-acid molecule the body produces on its own, and it has a substantial evidence base for pain. A 2023 meta-analysis of eleven double-blind randomized controlled trials, covering 774 patients, found that PEA meaningfully reduced pain (standardized mean difference 1.68).¹ A larger 2025 meta-analysis extended the picture to 18 studies and 1,196 patients.² But PEA is highly lipophilic and poorly water soluble, which makes consistent absorption a real formulation challenge rather than a given.

Ginger's gingerols and shogaols, which lower inflammatory signaling through the COX pathway, face the mirror-image issue. Ginger has genuine data behind it, including reduced inflammatory markers in joint pain and roughly a 25 percent reduction in exercise-induced muscle pain over eleven days.³ ⁴ Yet gingerols are notoriously poorly bioavailable on their own, so the amount that reaches circulation from a standard extract can be disappointing relative to the dose consumed.

In both cases the ingredient is not the weak link. The delivery is.

Delivery Chemistry: Closing the Gap Between Dose and Effect

Because absorption is a physical problem, it has physical solutions, and this is where formulation stops being about the number on the label and starts being about engineering. One well-characterized approach is a phospholipid complex, sometimes called a phytosome, in which the active molecule is bound to phospholipids such as those found in sunflower lecithin. The phospholipid acts as a molecular escort across the water-and-fat barriers of the gut, a legitimate technique for improving the absorption of poorly soluble actives.

A note of caution belongs here. The word "liposomal" appears on many supplement labels, but true liposomes are phospholipid bilayer vesicles, and simply blending an ingredient with oil or lecithin does not create one. In practice the term is often used loosely as marketing. A characterized phospholipid complex is a more honest description of what actually improves absorption.

Ginger can be addressed with its own delivery strategy: standardizing the gingerols and shogaols, then formulating so that both the water-loving and fat-loving compounds are carried across the gut lining rather than left behind. The principle is the same throughout. If a compound cannot get in, raising the dose is the wrong lever. Improving the delivery is the right one.

The Bigger Picture

The most useful shift for anyone who reads labels is to stop asking how many milligrams are in the capsule and start asking how many the body can use. Dose is a claim. Bioavailability is the outcome. This is the reasoning behind how Relivaid is built: its PEA is formulated as a phytosomal phospholipid complex, and its ginger uses a polar/non-polar sandwiching delivery designed to carry standardized gingerols and shogaols across the gut, with 50 mg of caffeine as a complementary ingredient, in a maroon capsule formulated for occasional pain support and safe for daily use.*

References

1. Lang-Illievich K, et al. Nutrients. 2023. doi:10.3390/nu15061350.

2. Viña I, López-Moreno M. Nutrition Reviews. 2025. doi:10.1093/nutrit/nuae203.

3. Broeckel J, et al. Nutrients. 2025. doi:10.3390/nu17142365.

4. Black CD, et al. The Journal of Pain. 2010. PMID 20418184.